Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIA632 in Moderate to Severe Cutaneous Lichen Planus
NCT07775924Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Countries
- 4
01
Overview
A Phase 2 trial of GIA632 in lichen planus (LP), sponsored by Novartis. Started Sep 2026; status: recruiting.
02
Drugs
GIA632
03
Conditions
lichen planus (LP)
Beyond the preview
Go deeper on NCT07775924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775924.